Get the Stockscreener App
23.66
6.62%
1.47
After Hours:
23.73
0.07
+0.30%
Evolent Health Inc stock is traded at $23.66, with a volume of 2.54M.
It is up +6.62% in the last 24 hours and up +13.80% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$22.19
Open:
$22.6
24h Volume:
2.54M
Market Cap:
$2.71B
Revenue:
$2.18B
Net Income/Loss:
$-110.34M
P/E Ratio:
-23.20
EPS:
-1.02
Net Cash Flow:
$130.43M
1W Performance:
+20.16%
1M Performance:
+13.80%
6M Performance:
-21.81%
1Y Performance:
-20.63%
1D Range:
$22.40
$23.78
52W Range:
$17.98
$35.00
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health (NYSE:EVH) Stock Price Up 5.5% - MarketBeat
MarketBeat
Evolent Health, Inc. (NYSE:EVH) Shares Sold by Russell Investments Group Ltd. - Defense World
Defense World
Ratio Review: Analyzing Evolent Health Inc (EVH)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
The Dwinnex
A stock that deserves closer examination: Evolent Health Inc (EVH) - US Post News
US Post News
Sei Investments Co. Sells 613 Shares of Evolent Health, Inc. (NYSE:EVH) - Defense World
Defense World
ProShare Advisors LLC Acquires 1,962 Shares of Evolent Health, Inc. (NYSE:EVH) - Defense World
Defense World
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):